Meiji Yasuda Asset Management Co Ltd. Invests $3.24 Million in Healthpeak Properties, Inc. $DOC

Meiji Yasuda Asset Management Co Ltd. acquired a new stake in shares of Healthpeak Properties, Inc. (NYSE:DOC) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 151,440 shares of the real estate investment trust’s stock, valued at approximately $3,241,000.

Several other large investors have also recently added to or reduced their stakes in the stock. Clearstead Trust LLC lifted its position in Healthpeak Properties by 66.7% in the 2nd quarter. Clearstead Trust LLC now owns 1,357 shares of the real estate investment trust’s stock worth $29,000 after buying an additional 543 shares in the last quarter. Advocate Investing Services LLC purchased a new position in shares of Healthpeak Properties during the 4th quarter valued at $26,000. CYBER HORNET ETFs LLC acquired a new position in shares of Healthpeak Properties in the second quarter worth $33,000. Clearstead Advisors LLC increased its stake in shares of Healthpeak Properties by 166.3% in the fourth quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust’s stock worth $31,000 after acquiring an additional 1,216 shares during the last quarter. Finally, Elyxium Wealth LLC purchased a new stake in shares of Healthpeak Properties during the fourth quarter worth $31,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Stock Up 1.0%

Healthpeak Properties stock opened at $21.62 on Tuesday. The company has a market capitalization of $14.91 billion, a P/E ratio of 61.77, a P/E/G ratio of 2.50 and a beta of 1.01. The firm’s fifty day simple moving average is $21.41 and its 200-day simple moving average is $19.07. The company has a current ratio of 3.02, a quick ratio of 3.02 and a debt-to-equity ratio of 1.06. Healthpeak Properties, Inc. has a 1-year low of $15.70 and a 1-year high of $22.95.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings data on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.03 by $0.05. The firm had revenue of $771.58 million during the quarter, compared to analysts’ expectations of $725.64 million. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. Healthpeak Properties’s revenue for the quarter was up 11.1% on a year-over-year basis. During the same period in the prior year, the company posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. Sell-side analysts forecast that Healthpeak Properties, Inc. will post 1.77 earnings per share for the current fiscal year.

Healthpeak Properties Announces Dividend

The business also recently disclosed a monthly dividend, which will be paid on Friday, September 25th. Stockholders of record on Monday, September 14th will be issued a dividend of $0.1017 per share. The ex-dividend date of this dividend is Monday, September 14th. This represents a c) dividend on an annualized basis and a dividend yield of 5.6%. Healthpeak Properties’s dividend payout ratio is currently 348.57%.

Analyst Upgrades and Downgrades

DOC has been the subject of a number of research reports. Robert W. Baird lifted their price objective on Healthpeak Properties from $21.00 to $24.00 and gave the company an “outperform” rating in a research report on Thursday, August 13th. Citigroup upped their target price on Healthpeak Properties from $20.00 to $22.00 and gave the stock a “neutral” rating in a research report on Tuesday, August 11th. Royal Bank Of Canada raised their price target on Healthpeak Properties from $21.00 to $24.00 and gave the stock an “outperform” rating in a research note on Monday, August 10th. Morgan Stanley reiterated an “equal weight” rating and set a $22.00 price target (up from $20.00) on shares of Healthpeak Properties in a report on Thursday, June 11th. Finally, Wells Fargo & Company boosted their price target on Healthpeak Properties from $20.00 to $22.00 and gave the company an “equal weight” rating in a research note on Wednesday, July 15th. Four investment analysts have rated the stock with a Buy rating and fourteen have issued a Hold rating to the company. Based on data from MarketBeat, Healthpeak Properties presently has a consensus rating of “Hold” and a consensus price target of $21.66.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.